Laparoscopic Gastric Banding: A Minimally Invasive Surgical Treatment for Morbid Obesity

Zinzindohoué, Franck; Chevallier, Jean‐Marc; Douard, Richard; Elian, N; Ferraz, Jean-Marc; Blanche, J. P.; Berta, J L; Altman, Jean-Jacques; Safran, D.; Cugnenc, Paul-Henri

doi:10.1097/00000658-200301000-00001

Cited by 183 publications

(91 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…24 Chevallier et al in this 7-year study, had 11.1% of their patients undergoing an abdominal reoperation for perforation (0.2%), band slippage (0.78%), migration (0.3%), gastric necrosis (0.1%), esophageal dilatation (0.2%), incisional hernias (0.4%) and port problems (0.21%). Similar conversion and reoperation rates were reported by Zinzindohoue et al 21 In their study, twelve patients (2.4%) were converted to open surgery and a patient reoperation rate of 10.4% was reported as a result of abdominal complications. There were no reports of conversions in the LSG group but reoperation rates ranged from 4.9-11.4%.…”

Section: Blood Loss Complications Conversion To Open Surgery and Resupporting

confidence: 86%

“…13,14,19,26 Gastric prolapse (20%), incisional hernia (0.6%), reconnection of catheter (0.6%) and wound infection (4%) were also reported as complications resulting from LASGB. 21,25 Other life-threatening complications reported by Chevallier et al and accounting for 1.2% of their study population of 1,000 LASGB patients include gastric perforation (0.4%), acute respiratory distress (0.2%), pulmonary embolism (0.2%), migration (0.3%), and gastric necrosis (0.1%). 24 Chevallier et al in this 7-year study, had 11.1% of their patients undergoing an abdominal reoperation for perforation (0.2%), band slippage (0.78%), migration (0.3%), gastric necrosis (0.1%), esophageal dilatation (0.2%), incisional hernias (0.4%) and port problems (0.21%).…”

Section: Blood Loss Complications Conversion To Open Surgery and Rementioning

confidence: 90%

“…Fuks et al reported a mean operating time of 103 minutes The only LASGB study that gave details of operative time was that of Zinzindohoue et al that reported a mean operative time of 105 minutes in 500 patients who underwent laparoscopic surgery for morbid obesity between 1997 and 2001 with application of an adjustable gastric band in order to evaluate the early and late morbidity of laparoscopic adjustable gastric banding for morbid obesity and to assess the efficacy of this procedure. 21 Four of the articles studied documented the duration of hospital stay postsurgery. The average hospital stay for patients who underwent LSG was 2.7 (2-25) days but one patient who had gastric fistula stayed for 47 days.…”

Section: Operative Time Hospital Stay and Mortalitymentioning

confidence: 99%

“…12,23 The mean stay for LASGB patients was 2.7 (0-30) days. 13,21 Five of the articles reviewed reported on mortalities in their studies. The overall mortality rate following LSG was 0-0.8% 12,19,20,22 while that of LASGB was 0%.…”

Section: Operative Time Hospital Stay and Mortalitymentioning

confidence: 99%

See 3 more Smart Citations

Laparoscopic Adjustable Silicon Gastric Banding versus Sleeve Gastrectomy

Akpo¹

2009

WJOLS

View full text Add to dashboard Cite

Background and purpose: Obesity now forms one of the leading public health concerns globally. Several surgical options including sleeve gastrectomy exist for its treatment. Recently, laparoscopic gastric banding has been developed with the aim of providing a laparoscopically placed device that is safe and effective in generating substantial weight loss. The goal of this review is to compare the effectiveness and safety of laparoscopic adjustable silicon gastric banding (LASGB) and laparoscopic sleeve gastrectomy (LSG) in the treatment of morbid obesity by reviewing the methods of patient selection, operative time, conversion rate, complications, blood loss, postoperative morbidity and mortality, hospital stay, and quality of life. Material and methods:A systematic literature search was performed using Highwire press, Springer link, Medline, Medscape and Google, and article bibliographies to identify relevant evidence. Included studies must have reported outcome data for more than 40 patients aged 20 years and above with a minimum of one 1-year follow-up. The operating time, complications, blood loss, hospital stay, morbidity and mortality, and quality of life were reviewed. Results:The total number of patients enrolled was 4,519; the specific procedure totals were 3,714 for LAGB and 805 for LSG. The age range of the population studied was 13-79 years for LSG and 18-65 years for LAGB. The sex distribution had a male:female ratio of 1:4 for LAGB and 1:3 for LSG. The overall complication rate in this review varied from 1.7-11. 80% for LSG and 0.2-24% for LAGB. Conclusion:Laparoscopic sleeve gastrectomy though, forms a safe surgical option for weight loss treatment particularly in the veryvery-obese patients (BMI > 60 kg/m 2 ). LASGB gives satisfactory results and coupled with reversibility and low cost, it is an important tool in the long-term management of patients with morbid obesity.

show abstract

Section: Blood Loss Complications Conversion To Open Surgery and Resupporting

confidence: 86%

Section: Blood Loss Complications Conversion To Open Surgery and Rementioning

confidence: 90%

Section: Operative Time Hospital Stay and Mortalitymentioning

confidence: 99%

Section: Operative Time Hospital Stay and Mortalitymentioning

confidence: 99%

See 2 more Smart Citations

Laparoscopic Adjustable Silicon Gastric Banding versus Sleeve Gastrectomy

Akpo¹

2009

WJOLS

View full text Add to dashboard Cite

show abstract

“…This procedure is easily reversible and is increasing in popularity. Sleeve gastrectomy is a procedure where the greater curvature of the stomach is removed [7]. This procedure can be used alone or combined with biliopancreatic diversion.…”

Section: Bariatric Proceduresmentioning

confidence: 99%

Pharmacokinetic Changes Secondary to Roux en Y Gastric Bypass

Giuliano¹

2012

Adv Pharmacoepidem Drug Safety

View full text Add to dashboard Cite

Objective: To review the influence of Roux-en-Y gastric bypass (RYGB) on pharmacokinetic parameters of medications.Data sources: PubMed was searched from inception to September 2012 to identify studies. Search terms included bariatric surgery, gastric bypass, Roux-en-Y, pharmacokinetic, and absorption. Studies included for this review were limited to English language studies published in full.Data synthesis: Obesity is a major health care concern and is on the rise. This has led to an increasing number of bariatric surgeries. Such procedures may have profound effects on pharmacokinetic parameters of many medications depending on the extent of surgical changes that are made. Surgical procedures such as RYGB are most likely to affect medication absorption. Factors that may affect medication absorption in RYGB patients include changes in intestinal or gastric pH, surface area, intestinal metabolism and transport mechanisms. Published studies have been primarily conducted in RYGB patients and have shown varied effect on overall absorption of medications.Conclusions: RYGB may have profound effects on medication absorption. Predicting absorption is difficult due to interplay of several factors including, changes in intestinal surface area, intestinal metabolism, efflux pumps, active transporters and gastrointestinal pH. Future studies are needed, particularly studies evaluating medications that have a low bioavailability and are commonly used in the bariatric surgery population.

show abstract